Human engineered heart tissue: analysis of contractile force
Authors
- I. Mannhardt
- K. Breckwoldt
- D. Letuffe-Brenière
- S. Schaaf
- H. Schulz
- C. Neuber
- A. Benzin
- T. Werner
- A. Eder
- T. Schulze
- B. Klampe
- T. Christ
- M.N. Hirt
- N. Huebner
- A. Moretti
- T. Eschenhagen
- A. Hansen
Journal
- Stem Cell Reports
Citation
- Stem Cell Rep 7 (1): 29-42
Abstract
Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). This study describes the generation of 3D, strip-format, force-generating engineered heart tissues (EHT) from hiPSC-CM and their physiological and pharmacological properties. CM were differentiated from hiPSC by a growth factor-based three-stage protocol. EHTs were generated and analyzed histologically and functionally. HiPSC-CM in EHTs showed well-developed sarcomeric organization and alignment, and frequent mitochondria. Systematic contractility analysis (26 concentration-response curves) reveals that EHTs replicated canonical response to physiological and pharmacological regulators of inotropy, membrane- and calcium-clock mediators of pacemaking, modulators of ion-channel currents, and proarrhythmic compounds with unprecedented precision. The analysis demonstrates a high degree of similarity between hiPSC-CM in EHT format and native human heart tissue, indicating that human EHTs are useful for preclinical drug testing and disease modeling.